In conclusion, the upregulation of TREM2, APOE, CD33, TYROBP and MS4A in the spinal cord of ALS could be potential markers of the presence of the DAM state in ALS in addition to these genes positioning themselves as potential therapeutic targets in the disease. This evidence concerns the gene CD33 and amyotrophic lateral sclerosis.